These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 39137037)

  • 1. Screening for chronic kidney disease: change of perspective and novel developments.
    van Mil D; Kieneker LM; Heerspink HJL; Gansevoort RT
    Curr Opin Nephrol Hypertens; 2024 Nov; 33(6):583-592. PubMed ID: 39137037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review.
    Gheewala PA; Zaidi STR; Jose MD; Bereznicki L; Peterson GM; Castelino RL
    J Nephrol; 2018 Feb; 31(1):27-36. PubMed ID: 28181150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for a randomized study assessing the feasibility of home-based albuminuria screening among the general population: The THOMAS study.
    van Mil D; Kieneker LM; Evers-Roeten B; Thelen MHM; de Vries H; Hemmelder MH; Dorgelo A; van Etten RW; Heerspink HJL; Gansevoort RT
    PLoS One; 2022; 17(12):e0279321. PubMed ID: 36548281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association.
    Ortiz A; Wanner C; Gansevoort R;
    Eur J Prev Cardiol; 2022 Dec; 29(17):2211-2215. PubMed ID: 35997796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.
    Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME;
    BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS): a prospective, randomised, open-label implementation study.
    van Mil D; Kieneker LM; Evers-Roeten B; Thelen MHM; de Vries H; Hemmelder MH; Dorgelo A; van Etten RW; Heerspink HJL; Gansevoort RT
    Lancet; 2023 Sep; 402(10407):1052-1064. PubMed ID: 37597522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of home-based screening of the general population for albuminuria to prevent progression of cardiovascular and kidney disease.
    Pouwels XGLV; van Mil D; Kieneker LM; Boersma C; van Etten RW; Evers-Roeten B; Heerspink HJL; Hemmelder MH; Langelaan MLP; Thelen MHM; Gansevoort RT; Koffijberg H
    EClinicalMedicine; 2024 Feb; 68():102414. PubMed ID: 38299045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for chronic kidney disease in a community-based diabetes cohort in rural Guatemala: a cross-sectional study.
    Flood D; Garcia P; Douglas K; Hawkins J; Rohloff P
    BMJ Open; 2018 Jan; 8(1):e019778. PubMed ID: 29358450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quest for cardiovascular disease risk prediction models in patients with nondialysis chronic kidney disease.
    Streja E; Norris KC; Budoff MJ; Hashemi L; Akbilgic O; Kalantar-Zadeh K
    Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):38-46. PubMed ID: 33186224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP.
    Matsushita K; Kaptoge S; Hageman SHJ; Sang Y; Ballew SH; Grams ME; Surapaneni A; Sun L; Arnlov J; Bozic M; Brenner H; Brunskill NJ; Chang AR; Chinnadurai R; Cirillo M; Correa A; Ebert N; Eckardt KU; Gansevoort RT; Gutierrez O; Hadaegh F; He J; Hwang SJ; Jafar TH; Jassal SK; Kayama T; Kovesdy CP; Landman GW; Levey AS; Lloyd-Jones DM; Major RW; Miura K; Muntner P; Nadkarni GN; Nowak C; Ohkubo T; Pena MJ; Polkinghorne KR; Sairenchi T; Schaeffner E; Schneider MP; Shalev V; Shlipak MG; Solbu MD; Stempniewicz N; Tollitt J; Valdivielso JM; van der Leeuw J; Wang AY; Wen CP; Woodward M; Yamagishi K; Yatsuya H; Zhang L; Dorresteijn JAN; Di Angelantonio E; Visseren FLJ; Pennells L; Coresh J
    Eur J Prev Cardiol; 2023 Jan; 30(1):8-16. PubMed ID: 35972749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk prediction in people with chronic kidney disease.
    Matsushita K; Ballew SH; Coresh J
    Curr Opin Nephrol Hypertens; 2016 Nov; 25(6):518-523. PubMed ID: 27517136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria.
    McGill JB; Haller H; Roy-Chaudhury P; Cherrington A; Wada T; Wanner C; Ji L; Rossing P
    BMJ Open Diabetes Res Care; 2022 Jul; 10(4):. PubMed ID: 35790319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life-Time Risk, Screening and The Cost of Cardiovascular Comorbidities in CKD Patients.
    Zoccali C; Abd ElHafeez S; Dounousi E; Anastasi R; Tripepi G; Mallamaci F
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):85-90. PubMed ID: 27442374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.
    Matsushita K; Sang Y; Ballew SH; Astor BC; Hoogeveen RC; Solomon SD; Ballantyne CM; Woodward M; Coresh J
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1770-7. PubMed ID: 24876355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for chronic kidney disease: which strategy?
    Hallan SI; Stevens P
    J Nephrol; 2010; 23(2):147-55. PubMed ID: 20155721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease and cardiovascular disease: a focus on primary care.
    Singh TK; Arya V; Navaratnarajah N
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(3):212-8. PubMed ID: 24720454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light wine consumption is associated with a lower odd for cardiovascular disease in chronic kidney disease.
    Jespersen T; Kruse N; Mehta T; Kuwabara M; Noureddine L; Jalal D
    Nutr Metab Cardiovasc Dis; 2018 Nov; 28(11):1133-1139. PubMed ID: 30143406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective.
    Ferguson TW; Tangri N; Tan Z; James MT; Lavallee BDA; Chartrand CD; McLeod LL; Dart AB; Rigatto C; Komenda PVJ
    Kidney Int; 2017 Jul; 92(1):192-200. PubMed ID: 28433383
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.